Baricitinib for the treatment of rheumatoid arthritis-Reference-Cited by-同舟云学术

Baricitinib for the treatment of rheumatoid arthritis

Published:2016-08-05 Issue:9 Volume:12 Page:911-919
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Kubo Satoshi,Nakayamada Shingo,Tanaka Yoshiya

Funder

the University of Occupational and Environmental Health, Japan, through UOEH Grant for Advanced Research

Grant-In-Aid for Scientific Research from the Ministry of Health, Labor and Welfare of Japan, the Ministry of Education, Culture, Sports, Science and Technology of Japan

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/1744666X.2016.1214576

Reference44 articles.

1. Treating rheumatoid arthritis to target: recommendations of an international task force

2. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

3. Proposal for a new nomenclature of disease-modifying antirheumatic drugs: Table 1

4. The Age of Crosstalk: Phosphorylation, Ubiquitination, and Beyond

5. JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knowledge mapping of cell therapy in rheumatoid arthritis disease: a bibliometric analysis (2003-2022);2023-05-25

3. Rheumatoid Arthritis: Pathogenic Roles of Diverse Immune Cells;International Journal of Molecular Sciences;2022-01-14

4. B Cells in Rheumatoid Arthritis：Pathogenic Mechanisms and Treatment Prospects;Frontiers in Immunology;2021-09-28

5. Efficacy and safety of baricitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic DMARDs and/or biological DMARDs: Data from a local registry;Reumatología Clínica (English Edition);2020-12